Walker, MD Saint Francis Medical Center NASS Patient Safety Committee Member Cape Girardeau, MO Introduction and Mechanism of Action Glucagon-like peptide-1 (GLP-1) agonists are recognized for their efficacy in managing diabetes mellitus and aiding weight loss.1 They also reduce cardiovascular risk.2,3,4 The mechanism of action involves mimicking GLP-1, an incretin hormone that enhances insulin secretion after an oral glucose load.5,6 Beyond these effects, GLP-1 agonists are involved in inhibiting glucagon secretion, thus stabilizing blood glucose levels
Many people are suing GLP-1 manufacturers because of side effects like gastroparesis and other serious disorders
Ghanei E, Baghani M, Moravvej H, Talebi A, Abdollahimajd F
Harding CF, Pytte CL, Page KG, Ryberg KJ, Normand E, Remigio GJ, DeStefano RA, Morris DB, Voronina J, Lopez A, Stalbow LA, Williams EP, Abreu N
Its a Brand Management lesson
We used real-world omics from the deCODE study to gain a better understanding about the effects of semaglutide on other disease processes other than obesity
